The median GDF15 level in the PVOD group was 12.4-, 3.0-, 2.4-, 2.1-, and 2.4-fold higher than that in the control, IPAH, HPAH, Other PH, and COPD groups, respectively (Figure 1A). This evidence concerns the gene GDF15 and chronic obstructive pulmonary disease.